Literature DB >> 15828908

Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation.

Akio Kawamura1, Takashi Horie, Ichirou Tsuda, Atushi Ikeda, Hirotoshi Egawa, Emi Imamura, Jun-Ichi Iida, Hiromi Sakata, Tohru Tamaki, Kazutaka Kukita, Jun-ichi Meguro, Motoki Yonekawa, Masaharu Kasai.   

Abstract

There are many cases of amputation of ischemic limbs of dialysis patients due to diabetes, despite the availability of medicine therapy and vascular by-pass operations. As there is extensive ruin of the vascular bed due to diabetes, vascular regeneration therapy by stem cell implantation is effective. Thirty patients with ischemic limbs due to diabetes (not including type-I) and on dialysis for chronic renal failure (19 cases), diabetes (5 cases), dialysis patients without diabetes (4 cases), and arteriosclerosis obliterans (ASO, 2 cases) were treated by autologous peripheral blood stem cell (PBSC) implantation where imminent amputation was under consideration. Granulocyte Colony Stimulate Factor (G-CSF: 5 microg/kg/day) was administered subcutaneously for 4 days before PBSC collection, that was carried out using a centrifuge (Spectra and/or CS3000) via the vein. The collected PBSC, containing 4.2 x 10(7) of CD 34 positive cells, was divided into units of 0.5-1.0 mL and implanted, without any purification, to the ischemic area of the limbs in about 65 points. In 21 cases, normalization of limb temperature was observed by thermograph, and symptoms also improved. The result of this first attempt of PBSC implantation is that we were able to save 22 ischemic limbs. This is the first large report of the application of regenerative medicine to peripheral ischemic limbs.

Entities:  

Mesh:

Year:  2005        PMID: 15828908     DOI: 10.1111/j.1774-9987.2005.00218.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  12 in total

1.  Bone marrow derived stem cells in regenerative medicine as advanced therapy medicinal products.

Authors:  Giuseppe Astori; Sabrina Soncin; Viviana Lo Cicero; Francesco Siclari; Daniel Sürder; Lucia Turchetto; Gianni Soldati; Tiziano Moccetti
Journal:  Am J Transl Res       Date:  2010-05-15       Impact factor: 4.060

Review 2.  Clinical application of stem cells for therapeutic angiogenesis in patients with peripheral arterial disease.

Authors:  Kyung-Bok Lee; Dong-Ik Kim
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

3.  Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs.

Authors:  Akio Kawamura; Takashi Horie; Ichiro Tsuda; Yoshihiro Abe; Masahiro Yamada; Hidetoshi Egawa; Jun-ichi Iida; Hiromi Sakata; Kazuhiko Onodera; Tohru Tamaki; Hidenori Furui; Kazutaka Kukita; Jun-ichi Meguro; Motoki Yonekawa; Shinya Tanaka
Journal:  J Artif Organs       Date:  2006-12-21       Impact factor: 1.731

4.  Oral Mucosa Harbors a High Frequency of Endothelial Cells: A Novel Postnatal Cell Source for Angiogenic Regeneration.

Authors:  Jian Zhou; Jason H Rogers; Scott H Lee; DongMing Sun; Hai Yao; Jeremy J Mao; Kimi Y Kong
Journal:  Stem Cells Dev       Date:  2016-12-22       Impact factor: 3.272

Review 5.  Clinical Application of Endothelial Progenitor Cell: Are We Ready?

Authors:  Chao-Hung Wang; Po-Hsun Huang; Jaw-Wen Chen; Shing-Jong Lin; Ming-Feng Lee; Ning-I Yang; Wen-Jin Cherng
Journal:  Acta Cardiol Sin       Date:  2013-11       Impact factor: 2.672

6.  Toward a mouse model of hind limb ischemia to test therapeutic angiogenesis.

Authors:  Robert A Brenes; Caroline C Jadlowiec; Mackenzie Bear; Peter Hashim; Clinton D Protack; Xin Li; Wei Lv; Michael J Collins; Alan Dardik
Journal:  J Vasc Surg       Date:  2012-07-24       Impact factor: 4.268

Review 7.  Emerging hurdles in stem cell therapy for peripheral vascular disease.

Authors:  Xabier L Aranguren; Catherine M Verfaillie; Aernout Luttun
Journal:  J Mol Med (Berl)       Date:  2008-08-19       Impact factor: 4.599

8.  Systematic assessment in an animal model of the angiogenic potential of different human cell sources for therapeutic revascularization.

Authors:  G Robin Barclay; Olga Tura; Kay Samuel; Patrick Wf Hadoke; Nicholas L Mills; David E Newby; Marc L Turner
Journal:  Stem Cell Res Ther       Date:  2012-07-03       Impact factor: 6.832

Review 9.  Autologous bone marrow cell therapy for peripheral arterial disease.

Authors:  C Botti; C Maione; A Coppola; V Sica; G Cobellis
Journal:  Stem Cells Cloning       Date:  2012-09-06

Review 10.  Stem cell therapy for diabetic foot ulcers: a review of preclinical and clinical research.

Authors:  Lara Lopes; Ocean Setia; Afsha Aurshina; Shirley Liu; Haidi Hu; Toshihiko Isaji; Haiyang Liu; Tun Wang; Shun Ono; Xiangjiang Guo; Bogdan Yatsula; Jianming Guo; Yongquan Gu; Tulio Navarro; Alan Dardik
Journal:  Stem Cell Res Ther       Date:  2018-07-11       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.